Terms: = Prostate cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Treatment
38 results:
1. Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc.
Paschal HMP; Kabat CN; Papaconstadopoulos P; Kirby NA; Myers PA; Wagner TD; Stathakis S
J Appl Clin Med Phys; 2022 Sep; 23(9):e13715. PubMed ID: 35985698
[TBL] [Abstract] [Full Text] [Related]
2. 3D-T2W-TSE radiotherapy treatment planning MRI using compressed sensing acceleration for prostate cancer: Image quality and delineation value.
Wong OL; Poon DMC; Kam MKM; Lo GG; Fung WWK; Man SY; Xue C; Yu SK; Cheung KY; Yuan J
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e369-e377. PubMed ID: 35073460
[TBL] [Abstract] [Full Text] [Related]
3. SPOP mutation induces DNA methylation via stabilizing GLP/G9a.
Zhang J; Gao K; Xie H; Wang D; Zhang P; Wei T; Yan Y; Pan Y; Ye W; Chen H; Shi Q; Li Y; Zhao SM; Hou X; Weroha SJ; Wang Y; Zhang J; Karnes RJ; He HH; Wang L; Wang C; Huang H
Nat Commun; 2021 Sep; 12(1):5716. PubMed ID: 34588438
[TBL] [Abstract] [Full Text] [Related]
4. The role of N-cadherin/c-Jun/ndrg1 axis in the progression of prostate cancer.
Quan Y; Zhang X; Butler W; Du Z; Wang M; Liu Y; Ping H
Int J Biol Sci; 2021; 17(13):3288-3304. PubMed ID: 34512147
[TBL] [Abstract] [Full Text] [Related]
5. An unusual case of oedematous prostate volumetric changes observed over the course of radiotherapy on the MR linear accelerator.
Clough A; Bridge P; Hales R; McDaid L; Choudhury A; Eccles CL
J Med Imaging Radiat Sci; 2021 Mar; 52(1):147-151. PubMed ID: 33342695
[TBL] [Abstract] [Full Text] [Related]
6. Identification of Potential Key Genes and Pathways in Enzalutamide-Resistant prostate cancer Cell Lines: A Bioinformatics Analysis with Data from the Gene Expression Omnibus (GEO) Database.
Zheng L; Dou X; Ma X; Qu W; Tang X
Biomed Res Int; 2020; 2020():8341097. PubMed ID: 32724813
[TBL] [Abstract] [Full Text] [Related]
7. Management of low-risk prostate cancer in patients with enlarged glands and lower urinary tract symptoms: robotic total prostatectomy, a novel technique.
Pathak RA; Hemal AK
World J Urol; 2020 Apr; 38(4):829-836. PubMed ID: 31538243
[TBL] [Abstract] [Full Text] [Related]
8. Per-organ assessment of subject-induced susceptibility distortion for MR-only male pelvis treatment planning.
Glide-Hurst C; Nejad-Davarani S; Weiss S; Zheng W; Chetty IJ; Renisch S
Radiat Oncol; 2018 Aug; 13(1):149. PubMed ID: 30111376
[TBL] [Abstract] [Full Text] [Related]
9. Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging-Only Radiation Therapy.
Johnstone E; Wyatt JJ; Henry AM; Short SC; Sebag-Montefiore D; Murray L; Kelly CG; McCallum HM; Speight R
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):199-217. PubMed ID: 29254773
[TBL] [Abstract] [Full Text] [Related]
10. Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer.
Lee E; Wang J; Jung Y; Cackowski FC; Taichman RS
J Cell Biochem; 2018 Apr; 119(4):3697-3705. PubMed ID: 29236331
[TBL] [Abstract] [Full Text] [Related]
11. Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - Generalized technique for four different MR scanners.
Koivula L; Kapanen M; Seppälä T; Collan J; Dowling JA; Greer PB; Gustafsson C; Gunnlaugsson A; Olsson LE; Wee L; Korhonen J
Radiother Oncol; 2017 Dec; 125(3):411-419. PubMed ID: 29097012
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy.
Maspero M; van den Berg CAT; Zijlstra F; Sikkes GG; de Boer HCJ; Meijer GJ; Kerkmeijer LGW; Viergever MA; Lagendijk JJW; Seevinck PR
Phys Med Biol; 2017 Oct; 62(20):7981-8002. PubMed ID: 28825917
[TBL] [Abstract] [Full Text] [Related]
13. Identification of simvastatin-regulated targets associated with JNK activation in DU145 human prostate cancer cell death signaling.
Jung EJ; Chung KH; Kim CW
BMB Rep; 2017 Sep; 50(9):466-471. PubMed ID: 28803608
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning.
Guerreiro F; Burgos N; Dunlop A; Wong K; Petkar I; Nutting C; Harrington K; Bhide S; Newbold K; Dearnaley D; deSouza NM; Morgan VA; McClelland J; Nill S; Cardoso MJ; Ourselin S; Oelfke U; Knopf AC
Phys Med; 2017 Mar; 35():7-17. PubMed ID: 28242137
[TBL] [Abstract] [Full Text] [Related]
15. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract] [Full Text] [Related]
16. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of ndrg1 promoter promotes proliferation and invasion of prostate cancer cells.
Li Y; Pan P; Qiao P; Liu R
Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
[TBL] [Abstract] [Full Text] [Related]
17. Cytotoxic effect of fluvastatin on MCF-7 cells possibly through a reduction of the mRNA expression levels of SGK1 and CAV1.
Salis O; Bedir A; Gulten S; Okuyucu A; Kulcu C; Alacam H
Cancer Biother Radiopharm; 2014 Nov; 29(9):368-75. PubMed ID: 25347557
[TBL] [Abstract] [Full Text] [Related]
18. A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer.
Korhonen J; Kapanen M; Keyriläinen J; Seppälä T; Tenhunen M
Med Phys; 2014 Jan; 41(1):011704. PubMed ID: 24387496
[TBL] [Abstract] [Full Text] [Related]
19. Molecular functions of the iron-regulated metastasis suppressor, ndrg1, and its potential as a molecular target for cancer therapy.
Fang BA; Kovačević Ž; Park KC; Kalinowski DS; Jansson PJ; Lane DJ; Sahni S; Richardson DR
Biochim Biophys Acta; 2014 Jan; 1845(1):1-19. PubMed ID: 24269900
[TBL] [Abstract] [Full Text] [Related]
20. A novel implementation of mARC treatment for non-dedicated planning systems using converted IMRT plans.
Dzierma Y; Nuesken F; Licht N; Ruebe C
Radiat Oncol; 2013 Aug; 8():193. PubMed ID: 23915350
[TBL] [Abstract] [Full Text] [Related]
[Next]
